CD8A and melanoma: Furthermore, the high granularity of CD8+ T cell populations characterized in scRNAseq analysis of the mouse data, allowed us to identify which were the specific CD8+ T subpopulations responding to ICB in patients, using as input published melanoma ICB response signatures obtained from single cell or bulk RNA sequencing.